HOME   ABOUT   DOSAGE FORMS   NEWS   FACILITIES   CAREERS   CONTACT 
  Skip Navigation LinksHOME NEWS

PRESS RELEASES AND OTHER NEWS
MEDIA INQUIRIES

Sally Langa
30 North Jefferson Road
Whippany, NJ 07981
973.428.4087
services@halopharma.com
MAY, 2013
Halo Pharma And Altus Formulation Announce New Formal Collaboration

Halo Pharma today announced that it has taken a minority ownership position in, and established a formal collaboration with, the drug formulation and development company Altus Formulation Inc. With this new investment in, and association with, Altus Formulations, Halo takes a first step in offering to clients, when needed, an entire suite of proprietary scientific and technical solutions designed to solve intractable issues in such areas as drug solubility, bioavailability, tamper and abuse deterrence, and precisely managed drug dosage delivery. These proprietary solutions cover a wide range of non-sterile and sterile dosage forms. One such area requiring solution is the currently much discussed question of the need for abuse resistance for narcotic analgesic and other frequently abused CNS drugs.
READ MORE 
APRIL, 2013
Halo appoints Roberto Darienzo in the position of Chief Operating Officer.

Roberto was born in Brazil and is a graduate Engineer from F.E.I. University in Sao Paulo. He has a second degree in Business Administration from Mackenzie University and over 30 years of industrial experience, with 22 of them in technical and international general management roles in the pharmaceutical industry. Most recently, and since leaving Sanofi-Aventis in 2005, where he was based in Germany, to return to the Americas, he became Vice President Americas Region for Schering-Plough and subsequently for Merck with responsibility for 13 sites in North and South America.
READ MORE 
AUGUST 1, 2012
Halo Pharmaceutical Completes Acquisition of Mirabel (Montreal, Quebec) Facility from Teva Canada.

Teva Canada and Halo Pharmaceutical announced today that they have completed the sale of Teva's Mirabel (Montreal, Quebec) manufacturing facility to Halo Pharmaceutical.
READ MORE 
PRIVACY POLICY   TERMS OF USE   SITE MAP   CONTACT   ©2010-2014 HALO Pharmaceutical Inc, NJ, USA.